xcube launches CVPE: A New Asset Class for Family Offices and UHNWIs
SINGAPORE, March 12, 2024 /PRNewswire/ — Singapore-based corporate venture studio xcube has announced the launch of Corporate Venture Portfolio Equities (CVPE), a new asset class aiming to disrupt traditional investment models. Unlike conventional methods that focus on individual startups, CVP
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, March 11, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-0755 KUBERA GOLD CORP. (“KBRA”)BULLETIN TYPE: New Listing- IPO-SharesBULLETIN DATE: March 11, 2024TSX Venture Tier 2 Company The Company’s Initial Public Offering (‘IPO’) Prospectus d
Jorie Koster-Hale Named CEO at Falling Colors Corporation
SANTA FE, N.M., March 11, 2024 /PRNewswire/ — Data and financial processing company Falling Colors Corporation (FCC) has named Jorie Koster-Hale as its new CEO. Koster-Hale, who joined FCC in 2018, holds a BA in linguistics (Pomona College) and a PhD in Cognitive Neuroscience (MIT). Prior to
Global Human Growth Hormone Market Report 2024 – Rapid Development of New Novel Recombinant Human Growth Hormones is Forecast to Drive the Market Forward – A $8.73 Billion Forecasted Market by 2028
DUBLIN, March 11, 2024 /PRNewswire/ — The “Global Human Growth Hormone Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Human Growth Hormone Market was estimated to be USD 5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. – ANTX
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AN2 Therapeutics, Inc. (“AN2” or the “Company”) (NASDAQ: ANTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ex
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dun & Bradstreet Holdings, Inc. – DNB
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dun & Bradstreet Holdings, Inc. (“DNB” or the “Company”) (NYSE: DNB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. – CTLT
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7
AMBEV’S 2023 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE
SÃO PAULO, March 11, 2024 /PRNewswire/ — Ambev S.A. [B3: ABEV3; NYSE: ABEV] announces that the Company’s annual report on Form 20-F for the year ended December 31, 2023 was filed with the U.S. Securities and Exchange Commission – SEC (“SEC”) on March 11, 2024 and is av
